Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans to release its first quarter 2020 financial results after market close on Tuesday, June 9, 2020.
Management will hold a conference call to review the company’s first quarter 2020 performance starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Senseonics website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 877-883-0383 (US/Canada) or 412-902-6506 (International), passcode 9741409, approximately ten to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM Systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005826/en/
Copyright Business Wire 2020